Regurgitation of esophageal mucosa.
Gesundheit
Benjamin
B
Department of Bone Marrow Transplantation, Cancer Immunotherapy & Immunobiology Research Center, Hadassah University Hospital, Jerusalem, Israel.
Resnick
Igor B
IB
D000328:Adult; D002066:Busulfan / Q000009:adverse effects; D004941:Esophagitis / Q000139:chemically induced*; D004947:Esophagus / Q000187:drug effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D052016:Mucositis / Q000139:chemically induced*; D019653:Myeloablative Agonists / Q000009:adverse effects; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy; D019172:Transplantation Conditioning / Q000009:adverse effects; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives; D014839:Vomiting / Q000209:etiology*
D019653:Myeloablative Agonists; D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine